|
|
| PMID |
|
|
| TITLE |
|
| Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer. |
|
| ABSTRACT |
|
|
|
| Epidemiological studies indicate that ovarian cancer is an endocrine-related tumour. We conducted a case-control comparison to assess the androgen receptor (AR) exon 1 polymorphic CAG repeat length (CAG(n)) as a risk factor for epithelial ovarian cancer. AR CAG(n) was determined for 319 case subjects with ovarian adenocarcinoma and 853 unaffected control subjects (comprising 300 unrelated adult female monozygotic twins, and 553 adult females sampled randomly from the population using the electoral rolls). The CAG(n) distributions of case subjects and control subjects were compared as a continuum, and by dichotomising alleles according to different CAG(n) cut-points. Logistic regression was used to calculate age-adjusted odds ratio (OR) estimates. Analyzed as a continuous variable, there was no difference between case subjects and control subjects for the smaller, larger or average allele sizes of the CAG(n) genotype, before or after adjusting for age. The mean (95% CI) for the average CAG(n) was 22.0 (21.8-22.2) for case subjects and 22.0 (21.9-22.1) for control subjects (p>.9). Analysis of CAG(n) as a dichotomous variable showed no difference between case subjects and control subjects for the median cutpoint (>/= 22), or for another cut-point previously reported to act as a modifier of breast cancer risk (>/= 29). Our data provide no evidence for an association between ovarian cancer risk and the genotype defined by the AR exon 1 CAG(n) polymorphism, although we cannot exclude small effects, or threshold effects in a small subgroup. |
| Copyright 2000 Wiley-Liss, Inc. |
|
| DATE PUBLISHED |
|
|
| HISTORY |
|
| PUBSTATUS |
PUBSTATUSDATE |
| pubmed |
2000/08/05 11:00 |
| medline |
2000/08/19 11:00 |
| entrez |
2000/08/05 11:00 |
|
| AUTHORS |
|
| NAME |
COLLECTIVENAME |
LASTNAME |
FORENAME |
INITIALS |
AFFILIATION |
AFFILIATIONINFO |
| Spurdle AB |
|
Spurdle |
A B |
AB |
|
Cancer Unit, Joint Experimental Oncology Programme, The Queensland Institute of Medical Research and The University of Queensland, Brisbane, Queensland, Australia. mandyS@qimr.edu.au |
| Webb PM |
|
Webb |
P M |
PM |
|
|
| Chen X |
|
Chen |
X |
X |
|
|
| Martin NG |
|
Martin |
N G |
NG |
|
|
| Giles GG |
|
Giles |
G G |
GG |
|
|
| Hopper JL |
|
Hopper |
J L |
JL |
|
|
| Chenevix-Trench G |
|
Chenevix-Trench |
G |
G |
|
|
|
| INVESTIGATORS |
|
|
| JOURNAL |
|
| VOLUME: 87 |
| ISSUE: 5 |
| TITLE: International journal of cancer |
| ISOABBREVIATION: Int J Cancer |
| YEAR: 2000 |
| MONTH: Sep |
| DAY: 01 |
| MEDLINEDATE: |
| SEASON: |
| CITEDMEDIUM: Print |
| ISSN: 0020-7136 |
| ISSNTYPE: Print |
|
| MEDLINE JOURNAL |
|
| MEDLINETA: Int J Cancer |
| COUNTRY: United States |
| ISSNLINKING: 0020-7136 |
| NLMUNIQUEID: 0042124 |
|
| PUBLICATION TYPE |
|
| PUBLICATIONTYPE TEXT |
| Comparative Study |
| Journal Article |
| Research Support, Non-U.S. Gov't |
|
| COMMENTS AND CORRECTIONS |
|
|
| GRANTS |
|
|
| GENERAL NOTE |
|
|
| KEYWORDS |
|
|
| MESH HEADINGS |
|
| DESCRIPTORNAME |
QUALIFIERNAME |
| Adenocarcinoma |
genetics |
| Adult |
genetics |
| Age Factors |
genetics |
| Aged |
genetics |
| Aged, 80 and over |
genetics |
| Alleles |
genetics |
| Case-Control Studies |
genetics |
| Exons |
genetics |
| Female |
genetics |
| Genotype |
genetics |
| Humans |
genetics |
| Middle Aged |
genetics |
| Ovarian Neoplasms |
genetics |
| Polymorphism, Genetic |
genetics |
| Receptors, Androgen |
genetics |
| Risk Factors |
genetics |
| Trinucleotide Repeats |
genetics |
| Twins, Monozygotic |
genetics |
|
| SUPPLEMENTARY MESH |
|
|
| GENE SYMBOLS |
|
|
| CHEMICALS |
|
| REGISTRYNUMBER |
NAMEOFSUBSTANCE |
| 0 |
Receptors, Androgen |
|
| OTHER ID's |
|
|
|
